Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.84 USD | +2.07% | +23.18% | -3.73% |
Financials (USD)
Sales 2024 * | 37.33K | Sales 2025 * | 57.5K | Capitalization | 199M |
---|---|---|---|---|---|
Net income 2024 * | -41M | Net income 2025 * | -39M | EV / Sales 2024 * | 5,341 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3,468 x |
P/E ratio 2024 * |
-4.83
x | P/E ratio 2025 * |
-5.43
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.48% |
Latest transcript on INmune Bio, Inc.
1 day | +2.07% | ||
1 week | +23.18% | ||
Current month | -7.74% | ||
1 month | -7.43% | ||
3 months | -8.21% | ||
6 months | +51.82% | ||
Current year | -3.73% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 10.84 | +2.07% | 115,735 |
24-04-24 | 10.62 | +4.73% | 114,535 |
24-04-23 | 10.14 | -4.56% | 178,613 |
24-04-22 | 10.62 | +26.94% | 687,880 |
24-04-19 | 8.37 | -4.89% | 69,216 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.73% | 193M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- INMB Stock